These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1312 related articles for article (PubMed ID: 29518562)

  • 21. HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Eckert K; Kodsi S; Cooper C
    Am J Clin Pathol; 2019 Mar; 151(4):433-442. PubMed ID: 30649177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
    Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
    J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
    Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
    Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
    Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
    PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
    Rebolj M; Bonde J; Preisler S; Ejegod D; Rygaard C; Lynge E
    PLoS One; 2016; 11(1):e0147326. PubMed ID: 26789267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.
    Mehta N; Keung MHT; Pineda E; Lynn E; Fetene D; Lee A; Hougardy N; Heinrichs A; Chan HTM; Arbyn M; Saville M; Hawkes D
    Microbiol Spectr; 2024 Oct; 12(10):e0149324. PubMed ID: 39258912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.
    Stoler MH; Wright TC; Sharma A; Apple R; Gutekunst K; Wright TL;
    Am J Clin Pathol; 2011 Mar; 135(3):468-75. PubMed ID: 21350104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of high-performance human papillomavirus testing to improve cervical cancer screening in China: a prospective population-based multicentre cohort study.
    Yin J; Zhang S; Li Z; Li Y; Wang H; Zhang X; Pan Q; Chen W; Luo X; Sun X; Zhao F; Qiao Y
    Clin Microbiol Infect; 2024 Sep; 30(9):1190-1196. PubMed ID: 38599463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology Characteristics and Potential Cervical Cancer Screening Value of Vulvar Human Papillomavirus in Chinese Women: A Multicenter Cross-Sectional Study.
    Li X; Xie H; Fu Y; Zhang X; Dong X; Ji Y; Lu W; Wang X
    Arch Pathol Lab Med; 2024 Sep; 148(9):1035-1040. PubMed ID: 38059501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of cobas 4800 high-risk HPV test as a tool in cervical cancer screening and cytology triage].
    Chen W; Yu LL; Wang H; Fu CJ; Chen F; Cao YQ; Kang LN; Zhang X; Zhao FH; Geng L; Yu L
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):543-8. PubMed ID: 22967475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
    Cook DA; Mei W; Smith LW; van Niekerk DJ; Ceballos K; Franco EL; Coldman AJ; Ogilvie GS; Krajden M
    BMC Cancer; 2015 Dec; 15():968. PubMed ID: 26674353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNIPER: a novel assay for human papillomavirus testing among women in Guizhou, China.
    Belinson SE; Wulan N; Li R; Zhang W; Rong X; Zhu Y; Wu R; Belinson JL
    Int J Gynecol Cancer; 2010 Aug; 20(6):1006-10. PubMed ID: 20683409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.
    Dun C; Yuan M; Zhao X; Hu S; Arbyn M; Zhao F
    Cancer Med; 2024 Jun; 13(11):e7316. PubMed ID: 38828559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary HPV testing verification: A retrospective ad-hoc analysis of screening algorithms on women doubly tested for cytology and HPV.
    Tracht J; Wrenn A; Eltoum IE
    Diagn Cytopathol; 2017 Jul; 45(7):580-586. PubMed ID: 28436211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
    Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.